Close Menu

NEW YORK (GenomeWeb) ­– Sequencing platform developer ReadCoor has been awarded a $2.5 million, two-year grant from the Bill and Melinda Gates Foundation to develop the infectious disease detection capabilities of its tissue-based fluorescent in situ sequencing (FISSEQ ) technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.